Advances in vaccine delivery and efficacy discussed at National Immunization Conference

NewsGuard 100/100 Score

Center for Vaccine Awareness and Research at Texas Children's Hospital

Advances in vaccine delivery and efficacy were discussed at the 44th National Immunization Conference sponsored by the Centers for Disease Control and Prevention (CDC). A research study by each of the four directors from the Center for Vaccine Awareness and Research at Texas Children's Hospital was presented. Held in Atlanta, more than 1,600 health professionals and medical experts attended the conference and explored innovative strategies for developing programs, policy and research to promote immunizations.

"We're proud of the body of research that the Center for Vaccine Awareness and Research was able to share at the National Immunization Conference," said Dr. Carol J. Baker, center executive director and chair of the Advisory Committee on Immunization Practices of the Centers for Disease Control and Prevention. "Our research studies on attitudes toward vaccinations, rotavirus prevention, cocooning to prevent pertussis and school-based immunization programs have provided the scientific community with valuable data that we can use in educating parents about immunizations."

Along with Baker, the center's three additional directors who had findings from their specialty area presented at the conference are: Drs. Julie A. Boom, director of Infant and Childhood Immunization; C. Mary Healy, director of Vaccinology and Maternal Immunization; and Amy B. Middleman, director of Adolescent and Young Adult Immunization.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Innovative malaria prodrug targets liver, enhances efficacy while reducing toxicity, preclinical studies show